← Issue №20/ week of Nov 15, 2026/Hepatology

MicroRNAs in aflatoxin B1-associated hepatocellular carcinogenesis: a scoping review of molecular networks, multiomics evidence, machine learning and translational potentials.

From GI Signals issue №20: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology systematic review · Nov 11, 2026 · BMC Gastro · IF 2.5

MicroRNAs in aflatoxin B1-associated hepatocellular carcinogenesis: a scoping review of molecular networks, multiomics evidence, machine learning and translational potentials.

Basic sciencebasic sciencetranslationalbiomarkerartificial intelligence
Clinical takeawayNo clinical action yet: this is a scoping review with limited direct human evidence; multicentre validation and harmonised assays are needed before clinical use.
What it foundCirculating miR-4651 discriminated AFB1-positive HCC with an AUROC of 0.85, 78.1% sensitivity, and 92.1% specificity in a human study.
ContextThis review highlights the scarcity of direct human evidence linking AFB1 exposure, microRNA dysregulation, and HCC, despite mechanistic plausibility.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Alaka OO … Ayoade F · BMC Gastroenterology · IF 2.5 · PubMed ↗Permalink
← Read the whole of issue №20 Every paper GI Signals surfaces gets a page like this one. All issues